These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

548 related articles for article (PubMed ID: 10190329)

  • 21. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
    Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
    N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer.
    Mangold E; Pagenstecher C; Friedl W; Mathiak M; Buettner R; Engel C; Loeffler M; Holinski-Feder E; Müller-Koch Y; Keller G; Schackert HK; Krüger S; Goecke T; Moeslein G; Kloor M; Gebert J; Kunstmann E; Schulmann K; Rüschoff J; Propping P
    Int J Cancer; 2005 Sep; 116(5):692-702. PubMed ID: 15849733
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms.
    Shia J; Klimstra DS; Nafa K; Offit K; Guillem JG; Markowitz AJ; Gerald WL; Ellis NA
    Am J Surg Pathol; 2005 Jan; 29(1):96-104. PubMed ID: 15613860
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer.
    Caldés T; Godino J; Sanchez A; Corbacho C; De la Hoya M; Lopez Asenjo J; Saez C; Sanz J; Benito M; Ramon Y Cajal S; Diaz-Rubio E
    Oncol Rep; 2004 Sep; 12(3):621-9. PubMed ID: 15289847
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toward new strategies to select young endometrial cancer patients for mismatch repair gene mutation analysis.
    Berends MJ; Wu Y; Sijmons RH; van der Sluis T; Ek WB; Ligtenberg MJ; Arts NJ; ten Hoor KA; Kleibeuker JH; de Vries EG; Mourits MJ; Hollema H; Buys CH; Hofstra RM; van der Zee AG
    J Clin Oncol; 2003 Dec; 21(23):4364-70. PubMed ID: 14645426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of germline MSH2 gene mutations in endometrial cancer not fulfilling the new clinical criteria for hereditary nonpolyposis colorectal cancer.
    Banno K; Susumu N; Hirao T; Yanokura M; Hirasawa A; Aoki D; Udagawa Y; Sugano K; Nozawa S
    Cancer Genet Cytogenet; 2003 Oct; 146(1):58-65. PubMed ID: 14499697
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of MSH2 and MLH1 mutations in Italian families with hereditary nonpolyposis colorectal cancer.
    Viel A; Genuardi M; Capozzi E; Leonardi F; Bellacosa A; Paravatou-Petsotas M; Pomponi MG; Fornasarig M; Percesepe A; Roncucci L; Tamassia MG; Benatti P; Ponz de Leon M; Valenti A; Covino M; Anti M; Foletto M; Boiocchi M; Neri G
    Genes Chromosomes Cancer; 1997 Jan; 18(1):8-18. PubMed ID: 8993976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations.
    Wu Y; Berends MJ; Mensink RG; Kempinga C; Sijmons RH; van Der Zee AG; Hollema H; Kleibeuker JH; Buys CH; Hofstra RM
    Am J Hum Genet; 1999 Nov; 65(5):1291-8. PubMed ID: 10521294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer.
    Casey G; Lindor NM; Papadopoulos N; Thibodeau SN; Moskow J; Steelman S; Buzin CH; Sommer SS; Collins CE; Butz M; Aronson M; Gallinger S; Barker MA; Young JP; Jass JR; Hopper JL; Diep A; Bapat B; Salem M; Seminara D; Haile R;
    JAMA; 2005 Feb; 293(7):799-809. PubMed ID: 15713769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and molecular characteristics of hereditary non-polyposis colorectal cancer families in Southeast Asia.
    Lee SC; Guo JY; Lim R; Soo R; Koay E; Salto-Tellez M; Leong A; Goh BC
    Clin Genet; 2005 Aug; 68(2):137-45. PubMed ID: 15996210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibody-based screening for hereditary nonpolyposis colorectal carcinoma compared with microsatellite analysis and sequencing.
    Christensen M; Katballe N; Wikman F; Primdahl H; Sørensen FB; Laurberg S; Ørntoft TF
    Cancer; 2002 Dec; 95(11):2422-30. PubMed ID: 12436451
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of selection strategies for genetic testing of patients with hereditary nonpolyposis colorectal carcinoma: effectiveness and cost-effectiveness.
    Reyes CM; Allen BA; Terdiman JP; Wilson LS
    Cancer; 2002 Nov; 95(9):1848-56. PubMed ID: 12404277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Microsatellite instability and expression of MLH1 and MSH2 in normal and malignant endometrial and ovarian epithelium in hereditary nonpolyposis colorectal cancer family members.
    Ichikawa Y; Lemon SJ; Wang S; Franklin B; Watson P; Knezetic JA; Bewtra C; Lynch HT
    Cancer Genet Cytogenet; 1999 Jul; 112(1):2-8. PubMed ID: 10432927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of six novel MSH2 and MLH1 germline mutations in HNPCC.
    Krüger S; Plaschke J; Jeske B; Görgens H; Pistorius SR; Bier A; Kreuz FR; Theissig F; Aust DE; Saeger HD; Schackert HK
    Hum Mutat; 2003 Apr; 21(4):445-6. PubMed ID: 12655562
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutations in MLH1 are more frequent than in MSH2 in sporadic colorectal cancers with microsatellite instability.
    Herfarth KK; Kodner IJ; Whelan AJ; Ivanovich JL; Bracamontes JR; Wells SA; Goodfellow PJ
    Genes Chromosomes Cancer; 1997 Jan; 18(1):42-9. PubMed ID: 8993979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Six novel heterozygous MLH1, MSH2, and MSH6 and one homozygous MLH1 germline mutations in hereditary nonpolyposis colorectal cancer.
    Rey JM; Noruzinia M; Brouillet JP; Sarda P; Maudelonde T; Pujol P
    Cancer Genet Cytogenet; 2004 Dec; 155(2):149-51. PubMed ID: 15571801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1.
    Syngal S; Fox EA; Eng C; Kolodner RD; Garber JE
    J Med Genet; 2000 Sep; 37(9):641-5. PubMed ID: 10978352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
    Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
    J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular analysis of hereditary nonpolyposis colorectal cancer in the United States: high mutation detection rate among clinically selected families and characterization of an American founder genomic deletion of the MSH2 gene.
    Wagner A; Barrows A; Wijnen JT; van der Klift H; Franken PF; Verkuijlen P; Nakagawa H; Geugien M; Jaghmohan-Changur S; Breukel C; Meijers-Heijboer H; Morreau H; van Puijenbroek M; Burn J; Coronel S; Kinarski Y; Okimoto R; Watson P; Lynch JF; de la Chapelle A; Lynch HT; Fodde R
    Am J Hum Genet; 2003 May; 72(5):1088-100. PubMed ID: 12658575
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histologic comparison of hereditary nonpolyposis colorectal cancer associated with MSH2 and MLH1 and colorectal cancer from the general population.
    Shashidharan M; Smyrk T; Lin KM; Ternent CA; Thorson AG; Blatchford GJ; Christensen MA; Lynch HT
    Dis Colon Rectum; 1999 Jun; 42(6):722-6. PubMed ID: 10378595
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 28.